Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Atricure Inc. buy UBS Group AG

Start price
€59.50
16.02.24 / 50%
Target price
€53.79
16.02.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 16.02.25. The prediction end date can be changed by UBS_Group_AG at any time.
Performance without dividends (%)
Name 1w 1m
Atricure Inc. - -
iShares Core DAX® 2.831% 1.236%
iShares Nasdaq 100 2.918% 0.640%
iShares Nikkei 225® 2.007% -2.135%
iShares S&P 500 2.257% 0.451%

Comments by UBS_Group_AG for this prediction

In the thread Atricure Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 53.789
Change
Ends at 16.02.25

AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $57.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat

Stopped prediction by UBS_Group_AG for Atricure Inc.

buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
29.09.23
€52.82
29.09.24
-
30.09.21